Teva Pharmaceutical Fin. Co B.V. (Curacao) Credit Rating

Зарегистрированный пользователь

Авторизуйтесь для доступа к разделам сайта. Пароль чувствителен к регистру клавиатуры

Имя пользователя :

Пароль:

Входить автоматически

Войти

Забыли имя пользователя или пароль?

Еще не зарегистрированы?

Зарегистрироваться сейчас для доступа к:

Рейтингам эмитентов.

Рейтинги свыше 170000 компаний, правительств и ценных бумаг структурированного финансирования.

Календарю мероприятий.

Информация об учебных семинарах, брифингах и телеконференциях.

Списку рейтингов на контроле.

Списки эмитентов, рейтинги которых могут быть изменены.

Рейтинговым методологиям.

Основные принципы и концепции, на которых базируются рейтинги Moody's.

Результаты 1 - 30 из 30

Страница 1 из 1 Next

Фильтр по:

Дата	Тип документа	Название	Источник
17 Dec 2023	Rating Action	Moody's affirms Teva's Ba2 ratings; outlook stable	Moody's Investors Service
04 Oct 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
15 Dec 2021	Rating Action	Moody's affirms Teva's Ba2 ratings; outlook revised to stable	Moody's Investors Service
08 Nov 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd	Moody's Investors Service
15 Dec 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd	Moody's Investors Service
07 Apr 2020	Rating Action	Moody's affirms Teva's Ba2 CFR; upgrades liquidity rating to SGL-2	Moody's Investors Service
14 Jan 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd	Moody's Investors Service
14 Aug 2019	Rating Action	Moody's affirms Teva's Ba2 CFR; outlook revised to negative	Moody's Investors Service
15 Feb 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd	Moody's Investors Service
12 Jan 2018	Rating Action	Moody's downgrades Teva to Ba2; outlook stable	Moody's Investors Service
14 Dec 2017	Rating Action	Moody's places Teva's Baa3 ratings on review for downgrade	Moody's Investors Service
03 Aug 2017	Rating Action	Moody's downgrades Teva's ratings to Baa3 from Baa2; outlook negative	Moody's Investors Service
31 Jan 2017	Rating Action	Moody's Affirms Teva's Baa2 rating; outlook changed to negative	Moody's Investors Service
25 Aug 2016	Announcement	Moody's: Teva's Loss of Two Copaxone Patents is Credit Negative	Moody's Investors Service
02 Aug 2016	Rating Action	Moody's Downgrades Teva's ratings to Baa2; Outlook Stable	Moody's Investors Service
27 Jul 2015	Rating Action	Moody's Downgrades Teva's Rating to Baa1; Ratings on Review for Downgrade	Moody's Investors Service
21 Apr 2015	Rating Action	Moody's Affirms Teva's A3 Rating; changes outlook to negative	Moody's Investors Service
19 Feb 2015	Rating Action	Moody's Affirms Teva's A3 rating; outlook changed to stable	Moody's Investors Service
13 Jun 2013	Rating Action	Moody's Affirms Teva's A3 rating; outlook to negative	Moody's Investors Service
13 Dec 2012	Rating Action	Moody's rates Teva's new notes A3; outlook stable	Moody's Investors Service
29 Mar 2012	Rating Action	Moody's rates Teva's new Euro notes A3; stable outlook	Moody's Investors Service
07 Nov 2011	Rating Action	Moody's rates Teva's new notes A3; stable outlook	Moody's Investors Service
01 Aug 2011	Announcement	Moody's: No effect on Teva's A3 rating from BRAVO trial	Moody's Investors Service
02 May 2011	Announcement	Moody's affirms Teva's A3 on Cephalon deal; stable outlook	Moody's Investors Service
18 Mar 2010	Announcement	Moody's affirms Teva Pharmaceuticals at A3; stable outlook	Moody's Investors Service
13 Jan 2010	Rating Action	Moody's upgrades Teva Pharmaceuticals to A3 from Baa1	Moody's Investors Service
14 Oct 2009	Rating Action	Moody's upgrades Teva to Baa1 from Baa2; positive outlook	Moody's Investors Service
18 May 2009	Rating Action	Moody's revises Teva's rating outlook to positive from stable	Moody's Investors Service
18 Jul 2008	Rating Action	Moody's affirms Teva Pharmaceuticals' Baa2 ratings	Moody's Investors Service
27 Jan 2006	Rating Action	MOODY'S ASSIGNS Baa2 RATINGS TO NEW SENIOR NOTES AND CONVERTIBLE DEBENTURES GUARANTEED BY TEVA PHARMACEUTICAL INDUSTRIES LIMITED ("TEVA"); STABLE RATING OUTLOOK	Moody's Investors Service

Результаты 1 - 30 из 30

Страница 1 из 1 Next

Рейтинги и аналитика

Программы и продукты

Новости и события

Зарегистрированный пользователь

Еще не зарегистрированы?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: